Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation

Human Molecular Genetics

Volumn 17, Issue 2, 2008, Pages 323-329

  Natividad, Angels ^a,b   Holland, Martin J ^a,c   Rockett, Kirk A ^b   Forton, Julian ^b   Faal, Nkoyo ^c   Joof, Hassan M ^c   Mabey, David C W ^a   Bailey, Robin L ^a   Kwiatkowski, Dominic P ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADOLESCENT; ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RISK FACTOR; TRACHOMA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GAMBIA; HUMANS; INTERLEUKIN-10; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRACHOMA;

CHLAMYDIA TRACHOMATIS;

EID: 37849010867     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm310     Document Type: Article

References (34)

1. Mariotti, S.P. (2004) New steps toward eliminating blinding trachoma. N. Engl. J. Med., 351, 2004-2007.
2. Mabey, D.C., Solomon, A.W. and Foster, A. (2003) Trachoma. Lancet, 362, 223-229.
3. Fenton, K.A. and Lowndes, C.M. (2004) Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm. Infect., 80, 255-263.
4. Mabey, D.C.W. (1992) The epidemiology and pathogenesis of trachoma. Rev. Med. Microbiol., 3, 112-119.
5. Natividad, A., Wilson, J., Koch, O., Holland, M.J., Rockett, K., Faal, N., Jallow, O., Joof, H.M., Burton, M.J., Alexander, N.D. et al. (2005) Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun., 6, 332-340.
6. Natividad, A., Cooke, G., Holland, M.J., Burton, M.J., Joof, H.M., Rockett, K., Kwiatkowski, D.P., Mabey, D.C. and Bailey, R.L. (2006) A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection. BMC Med. Genet., 7, 40.
7. Natividad, A., Hanchard, N., Holland, M.J., Mahdi, O.S., Diakite, M., Rockett, K, Jallow, O., Joof, H.M., Kwiatkowski, D.P., Mabey, D.C. et al. (2007) Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians. Genes Immun., 8, 288-295.
8. Mozzato-Chamay, N., Corbett, E.L., Bailey, R.L., Mabey, D.C., Raynes, J. and Conway, D.J. (2001) Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis. Genes Immun., 2, 153-155.
9. Mozzato-Chamay, N., Mahdi, O.S., Jallow, O., Mabey, D.C., Bailey, R.L. and Conway, D.J. (2000) Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis-endemic population. J. Infect. Dis., 182, 1545-1548.
10. Conway, D.J., Holland, M.J., Bailey, R.L., Campbell, A.E., Mahdi, O.S., Jennings, R., Mbena, E. and Mabey, D.C. (1997) Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect. Immun., 65, 1003-1006.
11. Faal, N., Bailey, R.L., Sarr, I., Joof, H., Mabey, D.C. and Holland, M.J. (2005) Temporal cytokine gene expression patterns in subjects with trachoma identify distinct conjunctival responses associated with infection. Clin. Exp. Immunol., 142, 347-353.
12. Burton, M.J., Bailey, R.L., Jeffries, D., Mabey, D.C. and Holland, M.J. (2004) Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect. Immun., 72, 7352-7356.
13. Yan, H., Yuan, W., Velculescu, V.E., Vogelstein, B. and Kinzler, K.W. (2002) Allelic variation in human gene expression. Science, 297 1143.
14. Pastinen, T. and Hudson, T.J. (2004) Cis-acting regulatory variation in the human genome. Science, 306, 647-650.
15. Knight, J.C., Keating, B.J., Rockett, K.A. and Kwiatkowski, D.P. (2003) In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat. Genet., 33, 469-475.
16. Wang, C., Tang, J., Geisler, W.M., Crowley-Nowick, P.A., Wilson, C.M. and Kaslow, R.A. (2005) Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. J. Infect. Dis., 191, 1084-1092.
17. Cohen, C.R., Koochesfahani, K.M., Meier, A.S., Shen, C., Karunakaran, K., Ondondo, B., Kinyari, T., Mugo, N.R., Nguti, R. and Brunham, R.C. (2005) Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-gamma. J. Infect. Dis., 192, 591-599.
18. Kinnunen, A.H., Surcel, H.M., Lehtinen, M., Karhukorpi, J., Tiitinen, A., Halttunen, M., Bloigu, A., Morrison, R.P., Karttunen, R. and Paavonen, J. (2002) HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum. Reprod., 17, 2073-2078.
19. Ohman, H., Tiitinen, A., Halttunen, M., Birkelund, S., Christiansen, G., Koskela, P., Lehtinen, M., Paavorien, J. and Surcel, H.M. (2006) IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis. Genes Immun., 7, 243-249.
20. Yang, X., Gartner, J., Zhu, L., Wang, S. and Brunham, R.C. (1999) IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J. Immunol., 162, 1010-1017.
21. Yang, X., HayGlass, K.T. and Brunham, R.C. (1996) Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J. Immunol., 156, 4338-4344.
22. Redpath, S., Ghazal, P. and Gascoigne, N.R. (2001) Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol. 9, 86-92.
23. Igietseme, J.U., Ananaba, G.A., Bolier, J., Bowers, S., Moore, T., Belay, T., Eko, F.Q., Lyn, D. and Black, C.M. (2000) Suppression of endogenous IL-10 gene expression in dendritic, cells enhances antigen presentation for specific Th1 induction: Potential for cellular vaccine development. J. Immunol., 164, 4212-4219.
24. McMahon-Pratt, D. and Alexander, J. (2004) Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol. Rev., 201, 206-224.
25. Kane, M.M. and Amser, D.M. (2001) The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol., 166, 1141-1147.
26. Cowles, C.R., Hirschhorn, J.N., Altshuler, D. and Lander, E.S. (2002) Detection of regulatory variation in mouse genes. Nat. Genet., 32, 432-437.
27. Barbarin, V., Xing, Z., Delos, M., Lison, D. and Huaux, F. (2005) Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am. J. Physiol. Lung Cell Mol. Physiol., 288, L841-L848.
28. Lee, C.G., Homer, R.J., Cohn, L., Link, H., Jung, S., Craft, J.E., Graham, B.S., Johnson, T.R. and Elias, J.A. (2002) Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J. Biol. Chem., 277 35466-35474.
29. Lazarus, M., Hajeer, A.H., Turner, D., Sinnott, P., Worthington, J., Ollier, W.E. and Hutchinson, I.V. (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J. Rheumatol., 24, 2314-2317.
30. Gibson, AW., Edberg, J.C., Wu, J., Westendorp, R.G., Huizinga, T.W. and Kimberly, R.P. (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol., 166, 3915-3922.
31. Crawley, E., Isenberg, D., Woo, P. and Kay, R. (1999) Interleukin-10 promoter polymorphism and lupus nephritis: Comment on the article by Mok et al. Arthritis Rheum., 42, 590-593.
32. Lim,, S., Crawley, E., Woo, P. and Barnes, P.J. (1998) Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet, 352, 113.
33. Llorente, L., Richaud-Patin, Y., Couderc, J., Alarcon-Segovia, D,, Ruiz-Soto, R., Alcocer-Castillejos, N., Alcocer-Varela, J., Granados, J., Bahena, S., Galanaud, P. et al. (1997) Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum., 40, 1429-1435.
34. Westendorp, R.G., Langermans, J.A., Huizinga, T.W., Elouali, A.H., Verweij, C.L., Boomsma, D.I., Vandenbroucke, J.P. and Vandenbrouke, J.P. (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet, 349, 170-173.